Hashimoto , Vertino &

Epigenetics, the cell-type-specific interpretation of genetic material, relies on DNA methylation and post-translational histone modifications to regulate gene function. Nucleosomes, the fundamental building unit that packages DNA, consist of approximately 146 bp of DNA wrapped approximately 1.8-times around a histone octamer that is evolutionarily conserved [1]. Histones are subject to considerable post-translational modifications including acetylation, methylation, ubiquitylation and sumoylation of lysine residues and methylation of arginine residues [2]. The combinatorial pattern of DNA and histone modifications constitutes an epigenetic ‘code’ that shapes gene-expression patterns by enabling or restricting the transcriptional potential of genomic domains. The code is written by sequence and site-specific modification enzymes and interpreted by effector molecules that mediate the assembly of higher-order chromatin structures. Epigenetic regulation plays a fundamental role in gene expression [3], DNA replication [4] and, recombination and repair [5], and is responsible for stem cell development [6] and cellular differentiation [7]. Moreover, alterations in epigenetic modifications accompany the aging process and contribute to the pathogenesis of cancer [8–14] and degenerative diseases [15,16]. One broad theme that has emerged is that a web of interactions tightly coordinates the modification of a segment of DNA and its associated histones, particularly histone H3. This article focuses on three protein domains (ATRX–Dnmt3–Dnmt3L [ADD], Cys–X–X–Cys [CXXC] and the methylCpG-binding domain [MBD]) and how they characterize the functional links between histone and DNA modification in mammalian cells. In particular we consider the relationship between DNA CpG methylation and histone H3 methylation on lysines 4 and 9 [17–23]. DNA methylation and histone lysine methylation are intimately connected with one another [17,19–21]. In fact, genomescale DNA methylation profiles suggest that DNA methylation is correlated to histone methylation patterns [18]. Specifically, DNA methylation is associated with the absence of H3K4 methylation (H3K4me0) and the presence of H3K9 methylation, but has little correlation with methylation of H3K27 [22]. In vivo studies support a molecular link between the mechanisms that maintain The combinatorial pattern of DNA and histone modifications constitutes an epigenetic ‘code’ that shapes gene-expression patterns by enabling or restricting the transcriptional potential of genomic domains. DNA methylation is associated with histone modifications, particularly the absence of histone H3 lysine 4 methylation (H3K4me0) and the presence of H3K9 methylation. This article focuses on three protein domains (ATRX–Dnmt3–Dnmt3L [ADD], Cys–X–X–Cys [CXXC] and the methyl-CpG-binding domain [MBD]) and the functional implications of domain architecture in the mechanisms linking histone methylation and DNA methylation in mammalian cells. The DNA methyltransferase DNMT3a and its accessory protein DNMT3L contain a H3K4me0-interacting ADD domain that links the DNA methylation reaction with unmodified H3K4. The H3K4 methyltransferase MLL1 contains a CpG-interacting CXXC domain that may couple the H3K4 methylation reaction to unmethylated DNA. Another H3K4 methyltransferase, SET1, although lacking an intrinsic CXXC domain, interacts directly with an accessory protein CFP1 that contains the same domain. The H3K9 methyltransferase SETDB1 contains a putative MBD that potentially links the H3K4 methylation reaction to methylated DNA or may do so through the interaction with the MBD containing protein MBD1. Finally, we consider the domain structure of the DNA methyltransferase DNMT1, its accessory protein UHRF1 and their associated proteins, and propose a mechanism by which DNA methylation and histone methylation may be coordinately maintained through mitotic cell division, allowing for the transmission of parental DNA and for the histone methylation patterns to be copied to newly replicated chromatin.

[1]  J. Yanagisawa,et al.  Characterization of BHC80 in BRAF-HDAC complex, involved in neuron-specific gene repression. , 2004, Biochemical and biophysical research communications.

[2]  T. Bestor,et al.  Epigenetic Decisions in Mammalian Germ Cells , 2007, Science.

[3]  P. Wade,et al.  The Mi-2/NuRD complex associates with pericentromeric heterochromatin during S phase in rapidly proliferating lymphoid cells , 2009, Chromosoma.

[4]  B. Cairns,et al.  DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45 , 2008, Cell.

[5]  Shireen A. Sarraf,et al.  Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. , 2004, Molecular cell.

[6]  P. Peterson,et al.  The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation , 2009, Nucleic acids research.

[7]  C. Bronner,et al.  UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. , 2009, Biochemical and biophysical research communications.

[8]  A. Fischer,et al.  The epigenetic bottleneck of neurodegenerative and psychiatric diseases , 2009, Biological chemistry.

[9]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[10]  M. Birke,et al.  The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. , 2002, Nucleic acids research.

[11]  Christof Niehrs,et al.  Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation , 2007, Nature.

[12]  J. Qin,et al.  ICBP90, a Novel Methyl K9 H3 Binding Protein Linking Protein Ubiquitination with Heterochromatin Formation , 2007, Molecular and Cellular Biology.

[13]  Tony Kouzarides,et al.  Histone H3 Lysine 4 Methylation Disrupts Binding of Nucleosome Remodeling and Deacetylase (NuRD) Repressor Complex* , 2002, The Journal of Biological Chemistry.

[14]  S. Kummar,et al.  DNA methylation: its role in cancer development and therapy. , 2008, Current problems in cancer.

[15]  E. Li,et al.  The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation , 2009, Nature Genetics.

[16]  En Li,et al.  Suv 39 h-Mediated Histone H 3 Lysine 9 Methylation Directs DNA Methylation to Major Satellite Repeats at Pericentric Heterochromatin , 2003 .

[17]  M. Pellegrini,et al.  Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency , 2010, Nature.

[18]  Chia-Lin Wei,et al.  Dynamic changes in the human methylome during differentiation. , 2010, Genome research.

[19]  Wendell A. Lim,et al.  Rapid Diversification of Cell Signaling Phenotypes by Modular Domain Recombination , 2010, Science.

[20]  Yang Shi,et al.  Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression , 2007, Nature.

[21]  M. Unoki,et al.  Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. , 2009, Biochemical pharmacology.

[22]  M. Esteller Epigenetic changes in cancer , 2011, F1000 biology reports.

[23]  D. Reinberg,et al.  Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. , 2002, Genes & development.

[24]  X. Nan,et al.  Retracted: Regulation of MBD1‐mediated transcriptional repression by SUMO and PIAS proteins , 2006, The EMBO journal.

[25]  K. Mitsuya,et al.  The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA , 2007, Nature.

[26]  Chengzu Long,et al.  Partitioning of Histone H3-H4 Tetramers During DNA Replication–Dependent Chromatin Assembly , 2010, Science.

[27]  Peter A. Jones,et al.  Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment. , 2007, Cancer research.

[28]  Guo-Liang Xu,et al.  The N-terminus of histone H3 is required for de novo DNA methylation in chromatin , 2009, Proceedings of the National Academy of Sciences.

[29]  Albert Jeltsch,et al.  Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail , 2010, Nucleic acids research.

[30]  J. Davie,et al.  5-Methylcytosine is not detectable in Saccharomyces cerevisiae DNA , 1984, Molecular and cellular biology.

[31]  A. Probst,et al.  Epigenetic inheritance during the cell cycle , 2009, Nature Reviews Molecular Cell Biology.

[32]  C. Allis,et al.  DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.

[33]  Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications. , 2009, The Biochemical journal.

[34]  Cara Merusi,et al.  Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA , 2010, Nucleic acids research.

[35]  A. Bird,et al.  The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites , 1999, Nature.

[36]  M. Nakao,et al.  Solution Structure of the Methyl-CpG Binding Domain of Human MBD1 in Complex with Methylated DNA , 2001, Cell.

[37]  Helen M. Blau,et al.  Reprogramming towards pluripotency requires AID-dependent DNA demethylation , 2010, Nature.

[38]  Xiaodong Cheng,et al.  A case study in cross-talk: the histone lysine methyltransferases G9a and GLP , 2010, Nucleic acids research.

[39]  E. Selker,et al.  A histone H3 methyltransferase controls DNA methylation in Neurospora crassa , 2001, Nature.

[40]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[41]  R. Reinhardt,et al.  Formation of nucleoprotein filaments by mammalian DNA methyltransferase Dnmt3a in complex with regulator Dnmt3L , 2008, Nucleic acids research.

[42]  L. Kristensen,et al.  DNA methylation, epimutations and cancer predisposition. , 2009, The international journal of biochemistry & cell biology.

[43]  H. Shibuya,et al.  DNA demethylation for hormone-induced transcriptional derepression , 2011, Nature.

[44]  D. Skalnik,et al.  CpG-binding Protein (CXXC Finger Protein 1) Is a Component of the Mammalian Set1 Histone H3-Lys4 Methyltransferase Complex, the Analogue of the Yeast Set1/COMPASS Complex* , 2005, Journal of Biological Chemistry.

[45]  M. Cosgrove,et al.  Mixed lineage leukemia: a structure–function perspective of the MLL1 protein , 2010, The FEBS journal.

[46]  C. Allis,et al.  Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa , 2003, Nature Genetics.

[47]  G. Maul,et al.  SETDB 1 : a novel KAP-1-associated histone H 3 , lysine 9-specific methyltransferase that contributes to HP 1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins , 2002 .

[48]  Monika S. Kowalczyk,et al.  Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX , 2007, Proceedings of the National Academy of Sciences.

[49]  S. Jacobsen,et al.  UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells , 2008, Nucleic acids research.

[50]  Xiaodong Cheng,et al.  UHRF1, a modular multi-domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications , 2009, Epigenetics.

[51]  Xing Zhang,et al.  The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules , 2008, Nature Structural &Molecular Biology.

[52]  M. Cleary,et al.  Binding to Nonmethylated CpG DNA Is Essential for Target Recognition, Transactivation, and Myeloid Transformation by an MLL Oncoprotein , 2004, Molecular and Cellular Biology.

[53]  C. Arrowsmith,et al.  Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1 , 2008, Nature.

[54]  S. Méresse,et al.  Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Yuriy L Orlov,et al.  Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. , 2009, Genes & development.

[56]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[57]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[58]  Y. Kohara,et al.  Role of the Dnmt3 family in de novo methylation of imprinted and repetitive sequences during male germ cell development in the mouse. , 2007, Human molecular genetics.

[59]  S. Grewal,et al.  Heterochromatin revisited , 2007, Nature Reviews Genetics.

[60]  A. Bird,et al.  Mbd1 Is Recruited to both Methylated and Nonmethylated CpGs via Distinct DNA Binding Domains , 2004, Molecular and Cellular Biology.

[61]  S. Pradhan,et al.  CXXC domain of human DNMT1 is essential for enzymatic activity. , 2008, Biochemistry.

[62]  Ke Zhang,et al.  Roles of the Clr4 methyltransferase complex in nucleation, spreading and maintenance of heterochromatin , 2008, Nature Structural &Molecular Biology.

[63]  H. Kimura,et al.  Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET , 2010, Nature.

[64]  Robert S. Illingworth,et al.  CpG islands influence chromatin structure via the CpG-binding protein Cfp1 , 2010, Nature.

[65]  R. Blumenthal,et al.  Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. , 2010, Biochemistry.

[66]  J. Trzcińska-Danielewicz,et al.  Expression of murine DNA methyltransferases Dnmt1 and Dnmt3a in the yeast Saccharomyces cerevisiae , 2007, Yeast.

[67]  M. Bycroft,et al.  Solution structure of the nonmethyl‐CpG‐binding CXXC domain of the leukaemia‐associated MLL histone methyltransferase , 2006, The EMBO journal.

[68]  H. Erdjument-Bromage,et al.  Histone demethylation by a family of JmjC domain-containing proteins , 2006, Nature.

[69]  E. Li,et al.  KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints , 2009, Nature.

[70]  D. Skalnik,et al.  Identification and Characterization of the Human Set1B Histone H3-Lys4 Methyltransferase Complex* , 2007, Journal of Biological Chemistry.

[71]  Archana Dhasarathy,et al.  The MBD protein family-reading an epigenetic mark? , 2008, Mutation research.

[72]  Yusuke Nakamura,et al.  Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism , 2008, Nature.

[73]  Kelly M. McGarvey,et al.  Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. , 2006, Cancer research.

[74]  E. Lander,et al.  The Mammalian Epigenome , 2007, Cell.

[75]  P. Park,et al.  CpG Islands Recruit a Histone H3 Lysine 36 Demethylase , 2010, Molecular cell.

[76]  Peter A. Jones,et al.  Cancer epigenetics: modifications, screening, and therapy. , 2008, Annual review of medicine.

[77]  R. Mantovani,et al.  Np95 Is a Histone-Binding Protein Endowed with Ubiquitin Ligase Activity , 2004, Molecular and Cellular Biology.

[78]  Michael Q. Zhang,et al.  Histone methylation marks play important roles in predicting the methylation status of CpG islands. , 2008, Biochemical and biophysical research communications.

[79]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[80]  S. Jacobsen,et al.  The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix , 2008, Nature.

[81]  H. Leonhardt,et al.  The multi-domain protein Np95 connects DNA methylation and histone modification , 2009, Nucleic acids research.

[82]  Manel Esteller,et al.  Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies , 2009, The Lancet Neurology.

[83]  N. Zeleznik-Le,et al.  Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia , 2010, Nature Structural &Molecular Biology.

[84]  J. P. Jackson,et al.  Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase , 2002, Nature.

[85]  S. Mandal,et al.  Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing , 2010, The FEBS journal.

[86]  S. Jacobsen,et al.  UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells , 2007, Science.

[87]  Helen M. Rowe,et al.  KAP1 controls endogenous retroviruses in embryonic stem cells , 2010, Nature.

[88]  A. Bird,et al.  MeCP2 binding to DNA depends upon hydration at methyl-CpG. , 2008, Molecular cell.

[89]  Thomas A Milne,et al.  MLL targets SET domain methyltransferase activity to Hox gene promoters. , 2002, Molecular cell.

[90]  Peter A. Jones,et al.  Selective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA , 2009, Molecular and Cellular Biology.

[91]  D. Reinberg,et al.  Chromatin structure and the inheritance of epigenetic information , 2010, Nature Reviews Genetics.